Author

Seowoo Park

Institution: Cellid (South Korea)

Observed institution: Cellid (South Korea)

ORCID: 0009-0002-7055-1417

Observed ORCID: 0009-0002-7055-1417

OpenAlex ID: A5015314480

Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform

2024 · Soojeong Chang, Kwang-Soo Shin, et al. · Proceedings of the National Academy of Sciences · 18

The Chimeric Adenovirus (Ad5/35) Expressing Engineered Spike Protein Confers Immunity against SARS-CoV-2 in Mice and Non-Human Primates

2022 · Seung-Phil Shin, Kwang-Soo Shin, et al. · Vaccines · 11

Boosting with variant-matched adenovirus-based vaccines promotes neutralizing antibody responses against SARS-CoV-2 Omicron sublineages in mice

2023 · Kwang-Soo Shin, Byung-Seok Kim, et al. · International Journal of Antimicrobial Agents · 6

Continuous Tracking for Effective Tackling: Ad5/35 Platform‐Based JN1 Lineage Vaccines Development in Response to Evolving SARS‐CoV‐2 Variants

2025 · Soojeong Chang, Jieun Shin, et al. · Journal of Medical Virology · 3

Development of broadly protective COVID-19 vaccine against up-to-date variants based on adenovirus type 5/35 vector platform

2023 · Chang-Yuil Kang, Soojeong Chang, et al. · The Journal of Immunology · 1

Limited Cross‐Neutralization of Emerging SARS‐CoV‐2 BA.3.2.2 After LP.8.1‐Updated Vaccination

2026 · Soojeong Chang, Jieun Shin, et al. · Journal of Medical Virology

The Ad5/35 Platform-Based Vaccines for SARS-CoV-2: A Strategy to Counter Evolving Variants 2324

2025 · Chang-Yuil Kang, Soojeong Chang, et al. · The Journal of Immunology

Evaluation of Simultaneous Production Strategies for Adenoviral Vector-Based SARS-CoV-2 Multivalent Vaccines via an Expanded Allele-specific Competitive Blocker PCR Quantification Method

2025 · Soojeong Chang, Hyemin Park, et al. · Analytical Chemistry

Works count: 8

Citation count: 39

H-index: 3

I10-index: 2